Cargando…
The Immune Response: Targets for the Treatment of Severe Sepsis
The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the infl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518958/ https://www.ncbi.nlm.nih.gov/pubmed/23251827 http://dx.doi.org/10.1155/2012/697592 |
_version_ | 1782252598961635328 |
---|---|
author | Bernard, Aline M. Bernard, Gordon R. |
author_facet | Bernard, Aline M. Bernard, Gordon R. |
author_sort | Bernard, Aline M. |
collection | PubMed |
description | The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies. |
format | Online Article Text |
id | pubmed-3518958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-35189582012-12-18 The Immune Response: Targets for the Treatment of Severe Sepsis Bernard, Aline M. Bernard, Gordon R. Int J Inflam Review Article The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies. Hindawi Publishing Corporation 2012 2012-12-03 /pmc/articles/PMC3518958/ /pubmed/23251827 http://dx.doi.org/10.1155/2012/697592 Text en Copyright © 2012 A. M. Bernard and G. R. Bernard. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Bernard, Aline M. Bernard, Gordon R. The Immune Response: Targets for the Treatment of Severe Sepsis |
title | The Immune Response: Targets for the Treatment of Severe Sepsis |
title_full | The Immune Response: Targets for the Treatment of Severe Sepsis |
title_fullStr | The Immune Response: Targets for the Treatment of Severe Sepsis |
title_full_unstemmed | The Immune Response: Targets for the Treatment of Severe Sepsis |
title_short | The Immune Response: Targets for the Treatment of Severe Sepsis |
title_sort | immune response: targets for the treatment of severe sepsis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518958/ https://www.ncbi.nlm.nih.gov/pubmed/23251827 http://dx.doi.org/10.1155/2012/697592 |
work_keys_str_mv | AT bernardalinem theimmuneresponsetargetsforthetreatmentofseveresepsis AT bernardgordonr theimmuneresponsetargetsforthetreatmentofseveresepsis AT bernardalinem immuneresponsetargetsforthetreatmentofseveresepsis AT bernardgordonr immuneresponsetargetsforthetreatmentofseveresepsis |